Skip to main content
logo
Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
21.52
-1.24 (-5.45%)
Jul 31, 2026, 4:00 PM EDT - Market closed

Nuvectis Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
25.1331.6318.5319.1319.995.74
Cash & Short-Term Investments
25.1331.6318.5319.1319.995.74
Cash Growth
-15.85%70.69%-3.10%-4.34%248.19%-
Other Current Assets
0.270.080.070.060.410.92
Total Current Assets
25.431.7118.6119.1920.415.83
Total Assets
25.431.7118.6119.1920.416.66

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
4.76.272.52.772.911.06
Accrued Expenses
6.487.026.44.212.830.54
Other Current Liabilities
----0.450.82
Total Current Liabilities
11.1813.38.896.986.192.42
Total Liabilities
11.1813.38.896.986.192.42

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Additional Paid-in Capital
119.96118.182.9666.4546.21.89
Retained Earnings
-105.74-99.69-73.25-54.25-31.99-12.9
Total Common Shareholders' Equity
14.2218.419.7112.214.22-11.01
Minority Interest
-----15.25
Shareholders' Equity
14.2218.419.7112.214.224.24
Total Liabilities & Equity
25.431.7118.6119.1920.416.66

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
25.1331.6318.5319.1319.995.74
Net Cash Growth
-15.85%70.69%-3.10%-4.34%248.19%-
Net Cash Per Share
1.111.451.081.231.581.34
Book Value
14.2218.419.7112.214.22-11.01
Book Value Per Share
0.630.840.570.781.12-2.58
Tangible Book Value
14.2218.419.7112.214.22-11.01
Tangible Book Value Per Share
0.630.840.570.781.12-2.58
SEC Filings: 10-K · 10-Q